Nalaganje...
Hsp110 mitigates α-synuclein pathology in vivo
Parkinson’s disease is characterized by the aggregation of the presynaptic protein α-synuclein and its deposition into pathologic Lewy bodies. While extensive research has been carried out on mediators of α-synuclein aggregation, molecular facilitators of α-synuclein disaggregation are still general...
Shranjeno v:
| izdano v: | Proc Natl Acad Sci U S A |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
National Academy of Sciences
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6883785/ https://ncbi.nlm.nih.gov/pubmed/31685606 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1903268116 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|